-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Contrasting Biote (NASDAQ:BTMD) and Ascend Wellness (OTC:AAWH)
Contrasting Biote (NASDAQ:BTMD) and Ascend Wellness (OTC:AAWH)
biote (NASDAQ:BTMD – Get Rating) and Ascend Wellness (OTC:AAWH – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability.
Analyst Ratings
This is a breakdown of recent ratings for biote and Ascend Wellness, as reported by MarketBeat.
Get biote alerts:Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
biote | 0 | 0 | 4 | 0 | 3.00 |
Ascend Wellness | 0 | 0 | 3 | 0 | 3.00 |
biote presently has a consensus target price of $10.25, indicating a potential upside of 138.65%. Ascend Wellness has a consensus target price of $9.00, indicating a potential upside of 542.86%. Given Ascend Wellness' higher probable upside, analysts clearly believe Ascend Wellness is more favorable than biote.
Volatility and Risk
biote has a beta of 0.37, meaning that its stock price is 63% less volatile than the S&P 500. Comparatively, Ascend Wellness has a beta of 2.63, meaning that its stock price is 163% more volatile than the S&P 500.Valuation & Earnings
This table compares biote and Ascend Wellness' gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
biote | N/A | N/A | $11.11 million | N/A | N/A |
Ascend Wellness | $332.38 million | 0.79 | -$122.66 million | ($0.46) | -3.04 |
biote has higher earnings, but lower revenue than Ascend Wellness.
Profitability
This table compares biote and Ascend Wellness' net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
biote | N/A | -20.05% | 5.99% |
Ascend Wellness | -21.54% | -35.74% | -7.98% |
Institutional & Insider Ownership
3.8% of biote shares are held by institutional investors. Comparatively, 0.0% of Ascend Wellness shares are held by institutional investors. 20.0% of biote shares are held by insiders. Comparatively, 24.9% of Ascend Wellness shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Summary
biote beats Ascend Wellness on 6 of the 10 factors compared between the two stocks.
About biote
(Get Rating)
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
About Ascend Wellness
(Get Rating)
Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods. Its cannabis product categories include flowers, pre-rolls, concentrates, vapes, edibles, and other cannabis-related products. As of December 31, 2021, the company operated 20 retail locations. It also sells its products to third-party licensed cannabis retail stores. The company was incorporated in 2018 and is headquartered in New York, New York.
Receive News & Ratings for biote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for biote and related companies with MarketBeat.com's FREE daily email newsletter.
纳斯达克(BTMD-GET Rating)和Ascend Wellness(场外交易代码:AAWH-GET Rating)都是小盘医疗公司,但哪只股票更好?我们将根据两家公司的风险实力、分析师建议、机构所有权、估值、股息、收益和盈利能力对它们进行比较。
分析师评级
这是MarketBeat报道的BioTE和Ascend Wellness最近的评级细目。
到达BioTE警报:销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
BioTE | 0 | 0 | 4. | 0 | 3.00 |
提升健康 | 0 | 0 | 3. | 0 | 3.00 |
BioTE目前的共识目标价为10.25美元,表明潜在涨幅为138.65%。Ascend Wellness的共识目标价为9美元,表明潜在上涨542.86%。鉴于Ascend Wellness更有可能上行,分析师显然认为Ascend Wellness比BioTE更有利。
波动性和风险
BioTE的贝塔系数为0.37,这意味着其股价的波动性比标准普尔500指数低63%。相比之下,Ascend Wellness的贝塔系数为2.63,这意味着其股价的波动性比标准普尔500指数高163%。估值与收益
此表比较了BioTE和Ascend Wellness的毛收入、每股收益(EPS)和估值。
总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
BioTE | 不适用 | 不适用 | 1111万美元 | 不适用 | 不适用 |
提升健康 | 3.3238亿美元 | 0.79 | -1.2266亿美元 | (0.46美元) | -3.04 |
BioTE的收益高于Ascend Wellness,但收入低于Ascend Wellness。
盈利能力
此表比较了BioTE和Ascend Wellness的净利润率、股本回报率和资产回报率。
净利润率 | 股本回报率 | 资产回报率 | |
BioTE | 不适用 | -20.05% | 5.99% |
提升健康 | -21.54% | -35.74% | -7.98% |
机构与内部人持股
BioTE 3.8%的股份由机构投资者持有。相比之下,机构投资者持有Ascend Wellness 0.0%的股份。BioTE 20.0%的股份由内部人士持有。相比之下,Ascend Wellness 24.9%的股份由内部人士持有。强大的机构持股表明,对冲基金、捐赠基金和大型基金管理公司相信,一家公司的长期表现将好于大盘。
摘要
BioTE在两只股票比较的10个因素中有6个超过了Ascend Wellness。
关于BioTE
(获取评级)
BioTE Corp.在激素优化领域经营医疗实践构建业务。该公司为BioTE认证的从业者提供了一个平台,以优化患者激素、维生素和矿物质水平的失衡,以及开出生物相同的激素疗法并推荐膳食补充剂。它还销售BioTE品牌的膳食补充剂;以及面向男性和女性的无菌颗粒插入工具包。该公司成立于2011年,总部设在得克萨斯州欧文。
关于Ascend Wellness
(获取评级)
Ascend Wellness Holdings,Inc.从事大麻消费包装商品的种植、制造和分销。其大麻产品类别包括鲜花、预卷、浓缩物、蒸气、可食用产品和其他与大麻有关的产品。截至2021年12月31日,该公司经营着20个零售点。它还将其产品销售给第三方许可的大麻零售店。该公司成立于2018年,总部设在纽约。
接受《BioTE日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对BioTE和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧